Owlstone Medical tipped as potential ‘Unicorn’ in The Spectator

Martin Vander Weyer tipped Owlstone as one of four high-tech start-ups with a chance of becoming the next "unicorn" - a British company that will be worth a billion dollars by the middle of the next decade.

Published on: 8 Aug 2016

Writing in The Spectator on 30 July 2016, Martin Vander Weyer tipped Owlstone as one of four high-tech start-ups with a chance of becoming the next “Unicorn” – a British company that will be worth a billion dollars by the middle of the next decade.

Spectator article

PDF version

(Owlstone is mentioned about halfway through underneath the subheading “The unicorn hunt”.)

Owlstone newsletter CTA

Talk to us about your biomarker research and how Breath Biopsy could help.

Contact Us